Establishing bioequivalence in complete and incomplete data designs using AUCs

Journal of Biopharmaceutical Statistics

Volumn 20, Issue 4, 2010, Pages 803-820

  Jaki, Thomas ^a   Wolfsegger, Martin J ^b   Lawo, John Philip ^b  

^a LANCASTER UNIVERSITY   (United Kingdom)

^b BAXTER INNOVATIONS GMBH   (Austria)

Author keywords

AUC; Batch design; Bioequivalence; Complete data design; Serial sampling design; Sparse sampling

Indexed keywords

AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CONFIDENCE INTERVAL; DRUG EXPOSURE; MATHEMATICAL MODEL; NONHUMAN; PERFORMANCE MEASUREMENT SYSTEM; PRIORITY JOURNAL; PROCESS DESIGN; SAMPLE SIZE; SIMULATION;

ALGORITHMS; ANIMALS; AREA UNDER CURVE; COMPUTER SIMULATION; CONFIDENCE INTERVALS; DRUG EVALUATION, PRECLINICAL; MODELS, STATISTICAL; PHARMACOKINETICS; SAMPLE SIZE; THERAPEUTIC EQUIVALENCY;

EID: 77952926181     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543401003618835     Document Type: Article

References (29)

1. Bailer, A. J. (1988). Testing for the equality of area under the curves when using destructive measurement techniques. Journal of Pharmacokinetics and Biopharmaceutics 16:303-309.
2. Bailer, A. J., Ruberg, S. J. (1996). Randomization tests for assessing the equality of area under curves for studies using destructive sampling. Journal of applied Toxicology 16:391-395.
3. Center for Drug Evaluation and Research (2001). Guidance for Industry. Statistical Approaches to Establishing Bioequivalence. U.S. Department of Health and Human Services Food and Drug Administration. Available at: http://www.fda.gov/ Cder/guidance/3616fnl.pdf, last accessed 2009-04-24.
4. Davison, A. C., Hinkley, D. V. (1997). Bootstrap Methods and Their Applications. Cambridge Series in Statistical and Probabilistic Mathematics. Cambridge: Cambridge University Press.
5. Efron, B. (1981). Nonparametric standard errors and confidence intervals (with discussion). Canadian Journal of Statistics 9:139-172.
6. Efron, B., Tibshirani, R. J. (1993). An Introduction to the Bootstrap. London: Chapman and Hall.
7. Fieller, E. C. (1954). Some problems in interval estimation. Journal of the Royal Statistical Society Series B (Methodological) 16:175-185.
8. Gagnon, R. C., Peterson, J. J. (1998). Estimation of confidence intervals for area under the curve from destructively obtained pharmacokinetic data. Journal of Pharmacokinetics and Biopharmaceutics 26:87-102.
9. Gibaldi, M., Perrier, D. (1982). Pharmacokinetics. New York: Marcel Dekker.
10. Hall, P. (1992). The Bootstrap and Edgeworth Expansion. New York: Springer.
11. Heinzl, H. (1996). A note on testing areas under the curve when using destructive measurement techniques. Journal of Pharmacokinetics and Biopharmaceutics 24:651-655.
12. Holder, D. J., Hsuan, F., Dixit, R., Soper, K. (1999). A method for estimating and testing area under the curve in serial sacrifice, batch, and complete data designs. Journal of Biopharmaceutical Statistics 9:451-464.
13. Hu, C., Moore, K. H. P., Kim, Y. H., Sale, M. E. (2004). Statistical issues in a modeling approach to assessing bioequivalence or PK similarity with presence of sparsely sampled subjects. Journal of Pharmacokinetics and Pharmacodynamics 31:321-339.
14. Jaki, T., Wolfsegger, M. J. (2009a). A theoretical framework for estimation of AUCs in complete and incomplete sampling designs. Statistics in Biopharmaceutical Research 1:176-184.
15. Jaki, T., Wolfsegger, M. J. (2010). PK: Basic Non-Compartmental Pharmacokinetics. R package version 1.2-2. Available at: http://www.r-project. org/
16. Jaki, T., Wolfsegger, M. J., Ploner, M. (2009). Confidence intervals for ratios of AUC's in the case of serial sampling: A comparison of seven methods. Pharmaceutical Statistics 8:12-24.
17. Nedelman, J. R., Gibiansky, E., Lau, D. T. W. (1995). Applying Bailer's method for AUC confidence intervals to sparse sampling. Pharmaceutical Research 12:124-128.
18. Nedelman, J. R., Jia, X. (1998). An extension of Satterthawaite's approximation applied to pharmacokinetics. Journal of Biopharmaceutical Statistics 8: 317-328.
19. Ploemen, J.-P., Kramer, H., Krajnc, E. I., Martin, I. (2007). The use of toxicokinetic data in preclinical safety assessment: a toxicologic pathologist perspective. Toxicologic Pathology 35:834-837.
20. Ploner, M. (2002). Bootstrap Confidence Intervals, An Overview and Comparisons by Means of Selected Applications. Ph.D. thesis, University of Vienna, Vienna, Austria.
21. R Development Core Team (2007). R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
22. Resnick, S. I. (1999). A Probability Path. Boston: Birkhäuser.
23. Satterthwaite, F. E. (1946). An approximate distribution of estimates of variance components. Biometrics Bulletin 2:110-114.
24. Singer, J., Berger, M. (2003). The Jackknife applied to incomplete blood sampling models. Pharmaceutical Statistics 2:161-166.
25. Tang-Liu, D. D.-S., Burke, P. J. (1988). The effect of azone on ocular levobunolol absorption: calculating the area under the curve and its standard error using tissue sampling compartments. Pharmaceutical Research 5:238-241.
26. Wolfsegger, M. J. (2007). Establishing bioequivalence in serial sacrifice designs. Journal of Pharmacokinetics and Pharmacodynamics 34:103-113.
27. Wolfsegger, M. J., Jaki, T. (2005). Estimation of AUC from 0 to infinity in serial sacrifice designs. Journal of Pharmacokinetics and Pharmacodynamics 32:757-766.
28. Wolfsegger, M. J., Jaki, T. (2009). Assessing systematic drug exposure in repeated dose toxicity studies in the case of complete and incomplete sampling. Biometrical Journal 51:1017-1026.
29. Yeh, C. (1990). Estimation and significant tests of area under the curve derived from incomplete blood sampling. American Statistical Association Proceedings of the Biopharmaceutical Section, pp. 74-81.